Yijia Group Corp. (YJGJ)
OTCMKTS · Delayed Price · Currency is USD
1.610
-0.890 (-35.60%)
At close: Oct 16, 2025
Yijia Group Revenue
Yijia Group had revenue of $103.90K in the quarter ending July 31, 2025, a decrease of -4.22%. This brings the company's revenue in the last twelve months to $2.66M, up 291.29% year-over-year. In the fiscal year ending April 30, 2025, Yijia Group had annual revenue of $2.66M with 366.47% growth.
Revenue (ttm)
2.66M
Revenue Growth
+291.29%
P/S Ratio
15.15
Revenue / Employee
2.66M
Employees
1
Market Cap
40.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 2.66M | 2.09M | 366.47% |
| Apr 30, 2024 | 570.69K | 532.69K | 1,401.83% |
| Apr 30, 2023 | 38.00K | -82.00K | -68.33% |
| Apr 30, 2022 | 120.00K | - | - |
| Apr 30, 2021 | - | - | - |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |